QGEN Research and Charts

QGEN - Qiagen NV (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2025-08-06 (Delayed quote data 2025-06-30)

Last 48.05	Change ⇑ +0.27 (+0.57%)	Volume 991,697
	Open 48.24	High 48.27	Low 47.66

8EMA (Daily) 47.47	40EMA (Daily) 45.20	50EMA (Daily) 44.73	STO (Daily) 85.306	MACD Hist (Daily) 0.037
8EMA (Weekly) 45.943	40EMA (Weekly) 43.48	50EMA (Weekly) 43.42	STO (Weekly) 93.851	MACD Hist (Weekly) 1.546


Company Profile
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.